FDA Approves Imipenem/Cilastatin + Relebactam
July 17th 2019RECARBRIO (imipenem, cilastatin, and relebactam) has been approved for the treatment of complicated urinary tract infections and complicated intra-abdominal bacterial infections where there are limited or no alternative treatments available.